A cancer cure once seemed like an ambitious yet distant dream. However, companies like Oxford Drug Design are transforming this dream into reality. The Yuan contributor, Oladimeji Ewumi, explores this exciting development in a recent interview, revealing how the landscape is changing for the better.

GenAI is one of the world’s most recently hyped technological developments and boasts impressive achievements. However, it falls short in critical areas, notably in its inability to significantly alleviate physician burnout, reports health writer and AI expert Oladimeji Ewumi.

The Reuters pharma conference is a central platform for pharma executives, patient advocacy groups, and other healthcare experts to share insights, exchange ideas, and be informed about evolving trends within the pharma industry, reports The Yuan contributor Oladimeji Ewumi.

The Bio-Europe Winter Conference is held in a different city each year - and last year, the rota fell on Munich. With a proven track record of fostering partnerships and innovation, the event showcased key biopharma trends set to impact healthcare over the next decades.

Experts in an AI panel session at the 2023 BIO-Europe winter conference highlighted some exciting biotech and pharma use cases in drug discovery for critical diseases while exploring the current regulatory outlook and other future possibilities. AI commentator Oladimeji Ewumi reports live.

Silicon Valley healthtech Theator crunches surgical data to optimize surgeons’ performance and ensure better patient experiences. Its co-founder and CEO Tamir Wolf lately sat down with The Yuan to present the firm’s latest advances set to transform surgical operations.

PurpleLab is a US healthtech firm that applies Big Data to achieve better provision of healthcare services for its clients. Its CEO Mark Brosso recently sat down with The Yuan to showcase the firm’s latest advances, which are poised to reconfigure the entire healthcare dynamic.

Exciting achievements in drug development, biotech, and pharma were showcased at the 2023 BIO-Europe Spring event, which ran live in Basel, Switzerland, from March 20-22 after being held online for the past three years. Biochemist and The Yuan contributor Oladimeji Ewumi reports.

The recent crop of AI startups spans the gamut of sectors. Real-time emotional subtitling firm Valence Vibrations eases communication among diverse groups. Its intriguing line piqued The Yuan’s interest. Its CEO Chloe Duckworth tells all in this exclusive interview with The Yuan.

Exploring the moral ramifications, equality issues, and fascinating potential of combining AI and open medical data in healthcare. Listen more as we explore patient safety, healthcare inequities, myths, regulatory roles, and the revolutionary potential of AI.

Investigating the transformational potential of AI and open medical data. Addressing biases, enhancing patient care, and releasing genetic insights for pharmaceutical research. Join us as we explore the exciting world of AI, open data, and its effects on underrepresented groups.

As the second most-populous continent looks to achieve universal health coverage, content marketing expert and AI commentator Oladimeji Ewumi shares his perspectives on its five top healthcare trends in 2023.

Millions of people search the web daily for images that reflect their unique dermatological needs, but scarce data under-represents people of color and other marginalized populations. The Yuan’s Oladimeji Ewumi relates how Harvard Prof Ellis Monk and Google Research teamed to redress this inequity.

Researchers at Massachusetts General Hospital devised a deep-learning model that predicts a person's 10-year risk of cardiovascular disease using a single chest X-ray. They presented the study result during the annual meeting of the Radiological Society of North America in November, The Yuan contributor Oladimeji Ewumi reports.

Weather changes can affect not just people’s moods, but their health as well, and as the effects of climate change are felt more widely, this is becoming a more pressing issue. However, research and further advances in AI mean that there are now more reasons for optimism.

This is The Yuan’s first global debate to mark the 110th birthday of Alan Turing, the pioneering father of AI. In light of Africa’s health tech expansion, biochemist Oladimeji Ewumi shares his insights and expertise on the benefits and drawbacks of open medical datasets in Africa’s digital health terrain.

Medtronic has always been at the forefront of medical technology, driving breakthrough innovations to transform patient care with next-generation digital solutions. Vice President and General Manager of Digital Surgery at Medtronic, George Murgatroyd, alongside consultant surgeons with the United Kingdom's National Health Service (NHS), shared interesting reviews on Medtronic's latest innovation; the first AI-powered surgical video and analytics platform tailor-made to improve surgical workflows.

In an exclusive interview with The Yuan, Lifespark Chief Executive Officer Joel Theisen spoke with Oladimeji Ewumi, and shared insights on how the company is leveraging artificial intelligence to help aging populations live healthier and longer.

In the past, Africa has often been a bit of a backwater in terms of technology and medical healthcare, but it is fast playing catch up thanks in part to the COVID-19 crisis. The African continent has embraced new technologies post pandemic and is well on its way to implementing a first-rate healthcare system that is the envy of the world.

Africa is under-represented on global genomic repositories, yet researchers have discovered genetic variants that can unlock new vistas for drug discovery in the genome of African populations. While closing existing paucities to foster the inclusion of Africa’s unique genetic datasets can be challenging, artificial intelligence can significantly help overcome such genetic biases.

Artificial intelligence-powered medical devices have become a growing part of everyday life in the healthcare sector. But as more medical devices get fully integrated with AI, can they perfectly bridge the gap between medtech innovators and patients in their quest for patient-centered care?

Africa’s biopharma market is the world’s fastest-growing and will be worth US$70 billion by 2030. Africa’s allure is rapid growth, not market size, and this is good news for big pharma keen on increasing market share in the second-largest continent’s booming biopharma terrain. Africans are under-represented on the clinical trial map, contributing less than 20 percent to all clinical trials conducted globally. Can Artificial intelligence (AI) solve Africa’s clinical trial challenges?

Healthcare delivery remains one of the core components of a nation’s health system. An efficient healthcare delivery system is data-driven, and its professionals must access data to diagnose conditions, treat diseases, prescribe medications, and offer consultations. Africa’s lack of data storage infrastructure, inefficient health data management, shortage of trained healthcare professionals, low healthcare budgets, and poor service integration is stopping data realize their full potential in Africa’s expansive health terrain. Use of data and real-world evidence (RWE) in Africa’s healthcare delivery system is an untapped goldmine.